<DOC>
	<DOCNO>NCT00190671</DOCNO>
	<brief_summary>This phase 2 portion phase 1/2 trial , test use pemetrexed cyclophosphamide combination treatment advance breast cancer . A single arm Phase 1 dose finding ( establish maximum tolerated dose ) study precedes randomize phase 2 portion .</brief_summary>
	<brief_title>A Study Pemetrexed Cyclophosphamide Given Every 21 Days Advanced Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>You must female least 18 year old . You must diagnose breast cancer . Your prestudy lab test within study requirement . You must willing take folic acid vitamin B12 . You pregnant breastfeed . You another illness doctor think would make unable participate . You currently take aspirin aspirinlike medicine unable stop day cycle therapy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Advanced Breast Cancer</keyword>
</DOC>